Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion type Assertion NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_head.
- NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion wasGeneratedBy ECO_0000203 NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_provenance.
- NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion wasDerivedFrom befree-2016 NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_provenance.
- NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion SIO_000772 10955790 NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_provenance.
- NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion evidence source_evidence_literature NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_provenance.
- NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_assertion description "[p53, mdm-2, p21, and mib-1 expression were assessed by immunohistochemical methods in primary tumors derived from 134 patients who took part in a randomized multicenter trial comparing docetaxel to sequential methotrexate and 5-fluorouracil (MF) in advanced breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292999.RA6_lqBSkSSH-eAOyLhqC6kwgeBhLrN4nWNzvjtxZ8Ye8130_provenance.